Ideally, future studies will also take into account the MDS genetic status of patients, with particular attention drawn to the splicing factor 3B subunit 1 (SF3B1) gene mutations, which appear to strongly influence the iron status of MDS patients. Here, SF3B1 is linked to myelodysplastic syndrome.